Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2016
For the six months, the company's net sales for the six months ended March 31, 2016 were $115.451 million compared to $108.4 million for the same period of fiscal 2015. For the six months ended March 31, 2016, net income was $8.859 million, or $0.94 diluted earnings per share, compared to net income of $7.4 million, or $0.77 diluted earnings per share, for the same period of fiscal 2015. Operating cash flow for the six months ended March 31, 2016 was $17.3 million, compared to $11.2 million for the same period of fiscal 2015. The operating cash flow for the six months ended March 31, 2016, combined with net borrowings of $16.0 million, was primarily used to invest $26.2 million in acquisitions of natural product businesses, $4.0 million in purchases of property, plant and equipment and $3.6 million in purchases of common stock for treasury. Income from operations was $14.336 million against $12.307 million a year ago. Adjusted EBITDA was $21.356 million against $18.814 million a year ago.